Santarus (SNTS) Tops Q3 Views
More News related to SNTS
- Stock Watch: BeaconEquity.com Issues Market Alert for Santarus Inc.
- Santarus (SNTS) Completes Enrollments for Budesonide MMX Phase III
- Santarus Announces Completion of Enrollment in European Phase III Clinical Trial for Budesonide MMX
- Morning Movers 12/02: ABCW, SNTS, BIOF, DYAX, SYMX Higher; HEB, PEIX Lower
- After-Hours Movers 12/01: SNTS, ABCW, RAME, GAME Higher; HEB, SWS, RGNC, LTXC Lower
More News related to Earnings
- XATA Corp. (XATA) Posts Break-Even Q4 EPS, Misses by 2c
- Big Lots (BIG) Posts Q3 EPS of $0.27, 9c Better than Estimates; Guides; OKs Share Repurchase of $150M
- Smith & Wesson (SWHC) Falls After Q2 Results As Demand Normalizes
- Quanex (NX) Posts Q4 adj.-EPS of $0.39, Tops Views
- EasyLink (ESIC) Posts Q3 EPS of $0.04, Misses by 2c
Santarus, Inc. (NASDAQ: SNTS) reports Q3 EPS of $0.09, ex-items, 8 cents better than the analyst estimate of $0.01. Revenue for the quarter was $39.5 million, which compares to the estimate of $36.47 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
